Bibliographic information

GuidelineClinical management of COVID-19: living guideline, 15 September 2022.
Year of Publication2022
Issuing InstitutionWHO

Recommendation

Maintained

In hospitalized patients with severe or critical COVID-19 and acute hypoxaemic respiratory failure (AHRF) not needing emergent intubation, we suggest high-flow nasal oxygen (HFNO) rather than standard oxygen therapy (SOT)

Recommended in favor

Conditional

Notes and Remarks

Remark The GDG chose not to make a recommendation regarding high-flow nasal oxygen (HFNO) versus continuous positive airway pressure (CPAP) due to uncertainty of the data. Clinicians should therefore choose between the two on the basis of considerations such as availability of devices and the supply of oxygen, their personal comfort and experience, and patient-specific considerations (such as claustrophobia that some patients experience with CPAP masks, and nasal discomfort that some patients experience with HFNO). The GDG elected to extend this recommendation to the paediatric age range (despite the absence of data), given the likely similar direction of benefit, but emphasized the need for more research in this population.

Practical Info There is no specific recommendation for the initial flow rate, FiO2, or titration scheme. Based on clinical experience of the panel, initial flow rates of between 50 and 60 L/min and initial FiO2 of 100% are suggested, titrated to patient SpO2 and work of breathing. In children, a fixed rate of 2 L/min/kg of body weight is suggested. For infection prevention precautions related to the use of these respiratory support devices, please refer to Section 5 on IPC. See also research needs.

Also Featured In

This recommendation also appears in the following guidelines:

Originally Developed
Guideline

Clinical management of COVID-19: living guideline, 23 June 2022.

Year2022
InstitutionWHO
Guideline

Clinical management of COVID-19: living guideline, 13 January 2023.

Year2023
InstitutionWHO
Guideline

Clinical management of COVID-19: living guideline, 18 August 2023

Year2023
InstitutionWHO
Guideline

Clinical management of COVID-19: living guideline, June 2025

Year2025
InstitutionWorld Health Organization